Nigeria is transitioning to Multiple Micronutrient Supplementation (MMS) to improve antenatal care. Learn about the benefits, ...
MMS, a global, data-focused clinical research organization (CRO), today announced it has been named a finalist in the 2026 ...
MMS, a global, data-focused clinical research organization (CRO), today announced that Somya Dunn, MD, has joined the company as Senior Medical Director, Safety Risk Management, further advancing the ...
Alina Amir went on to make the choice to address her silence the following several days after the video had spread, even ...
Looking back on government & technical consulting stocks’ Q3 earnings, we examine this quarter’s best and worst performers, ...
Think twice before searching for viral videos. This isn't another clickbait article - it's about understanding the real harm ...
If you are wondering whether Maximus at around US$94.44 is offering good value or asking too much, starting with a clear look at its valuation can help you frame that decision. The stock has had a ...
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...
The panel screened several PFAS compounds, including PFHxS, PFOA, PFOS, PFDA, PFUnDA and others. According to Quest, Kavanaugh’s overall results placed PFAS in her blood at 4.15 nanograms per ...
StockStory.org on MSN
MMS Q4 deep dive: Revenue shortfall and cautious optimism amid government contract delays
Government services provider Maximus (NYSE:MMS) in Q4 CY2025, with sales falling 4.1% year on year to $1.35 billion. The ...
StockStory.org on MSN
Maximus (NYSE:MMS) misses Q4 CY2025 sales expectations
Government services provider Maximus (NYSE:MMS) in Q4 CY2025, with sales falling 4.1% year on year to $1.35 billion. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results